Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 5,510.00
+280.00 (5.35%)
At close: Nov 13, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 37.5 billion as of November 13, 2026. It is the 34,566th most valuable company in the world and the 2,003rd biggest in South Korea. Its market cap has increased by 1.87% in one year.
Market Cap
37.50B
Enterprise Value
30.80B
Revenue
37.80B
Global Rank
Country Rank
#2,003 South Korea
PE Ratio
4.56
ChartMarket Cap Chart
Since January 26, 2021, Wonbiogen's market cap has decreased from 47.59B to 37.50B, a decrease of -21.20%. That is a compound annual growth rate of -4.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 37.50B | -20.86% |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
| Jan 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 155.51B |
| JW Shinyak | 132.42B |
| Sewoon Medical | 91.95B |
| CG MedTech | 85.70B |
| OSTEONIC | 77.24B |
| SCL Science | 66.29B |
| MEDYSSEY Co.,Ltd | 40.94B |
| KM Corporation | 37.49B |